| Second cancer risk up to 40 years after treatment for Hodgkin’s lymphoma M Schaapveld, BMP Aleman, AM van Eggermond, CPM Janus, ADG Krol, ... New England Journal of Medicine 373 (26), 2499-2511, 2015 | 565 | 2015 |
| Morbidity and mortality of inadvertent enterotomy during adhesiotomy AA Van Der Krabben, FR Dijkstra, M Nieuwenhuijzen, M Reijnen, ... Journal of British Surgery 87 (4), 467-471, 2000 | 554 | 2000 |
| Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood FE van Leeuwen, WJ Klokman, MB Veer, A Hagenbeek, ADG Krol, ... Journal of Clinical Oncology 18 (3), 487-487, 2000 | 546 | 2000 |
| Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk FA Van Nimwegen, M Schaapveld, CPM Janus, ADG Krol, EJ Petersen, ... JAMA internal medicine 175 (6), 1007-1017, 2015 | 460 | 2015 |
| Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma FA van Nimwegen, M Schaapveld, DJ Cutter, CP Janus, AD Krol, ... Journal of Clinical Oncology 34 (3), 2015 | 402 | 2015 |
| Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility MM De Jong, IM Nolte, GJ Te Meerman, WTA Van der Graaf, ... Journal of medical genetics 39 (4), 225-242, 2002 | 386 | 2002 |
| Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma MJA Engelen, HE Kos, PHB Willemse, JG Aalders, EGE de Vries, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2006 | 377 | 2006 |
| Increased cancer risk after liver transplantation: a population-based study EB Haagsma, VE Hagens, M Schaapveld, AP van den Berg, ... Journal of hepatology 34 (1), 84-91, 2001 | 375 | 2001 |
| Risk for valvular heart disease after treatment for Hodgkin lymphoma DJ Cutter, M Schaapveld, SC Darby, M Hauptmann, FA Van Nimwegen, ... Journal of the National Cancer Institute 107 (4), djv008, 2015 | 301 | 2015 |
| Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy WK de Jong, JLG Blaauwgeers, M Schaapveld, W Timens, ... European journal of cancer 44 (1), 123-130, 2008 | 264 | 2008 |
| Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study M Schaapveld, O Visser, MJ Louwman, EGE de Vries, PHB Willemse, ... Journal of Clinical Oncology 26 (8), 1239-1246, 2008 | 231 | 2008 |
| Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines FA Van Nimwegen, G Ntentas, SC Darby, M Schaapveld, M Hauptmann, ... Blood, The Journal of the American Society of Hematology 129 (16), 2257-2265, 2017 | 223 | 2017 |
| Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age DM van der Kolk, GH de Bock, BK Leegte, M Schaapveld, MJE Mourits, ... Breast cancer research and treatment 124, 643-651, 2010 | 222 | 2010 |
| Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma A Diepstra, M Niens, E Vellenga, GW Van Imhoff, IM Nolte, M Schaapveld, ... The Lancet 365 (9478), 2216-2224, 2005 | 198 | 2005 |
| Determination of TP53 Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III … JL Westra, M Schaapveld, H Hollema, JP de Boer, MMJ Kraak, D de Jong, ... Journal of clinical oncology 23 (24), 5635-5643, 2005 | 158 | 2005 |
| HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma A Diepstra, GW van Imhoff, HE Karim-Kos, A van den Berg, ... Journal of clinical oncology 25 (21), 3101-3108, 2007 | 157 | 2007 |
| The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands M Schaapveld, O Visser, WJ Louwman, PHB Willemse, EGE de Vries, ... Breast cancer research and treatment 110, 189-197, 2008 | 129 | 2008 |
| Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors NB Boekel, M Schaapveld, JA Gietema, NS Russell, P Poortmans, ... International Journal of Radiation Oncology* Biology* Physics 94 (5), 1061-1072, 2016 | 118 | 2016 |
| Increased colon cancer risk after severe Salmonella infection L Mughini-Gras, M Schaapveld, J Kramers, S Mooij, EA Neefjes-Borst, ... PloS one 13 (1), e0189721, 2018 | 117 | 2018 |
| Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin’s lymphoma predicts adverse outcome in older adult patients A Diepstra, GW van Imhoff, M Schaapveld, H Karim-Kos, A van den Berg, ... J Clin Oncol 27 (23), 3815-21, 2009 | 114 | 2009 |
Elisabeth de VriesProfessor of Medical Oncology, University Medical Center Groningen, Groningen, the NetherlandsVerified email at umcg.nl
